Yamanaka K, Okubo Y, Yasuda I, Saito N, et al. Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. J Dermatol 2022 Dec 13. doi: 10.1111/1346-8138.16667.
PMID: 36514850